# Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects

> **NCT01338350** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 96 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD5423
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01338350
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338350, "Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01338350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*